OA Clinic-Community CARE Model
NCT05349500 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2025-01-14
Summary
The purpose of this study is to test the OA Clinic-Community CARE Model (OA CARE) which will address all recommended components of knee/hip (osteoarthritis) OA care, include interventions for both patients and primary care providers (PCPs), and utilize a tailored approach that efficiently matches treatments with patients' needs.
The patient component of OA CARE will include evidence-based weight management and exercise programs for all participants (delivered through the YMCA), as well as tailored referrals to physical therapy, additional weight management or nutrition services, sleep-related services and psychological services.
The PCP component of OA CARE will include a video-based summary of current OA treatment guidelines (with emphasis on practical application), collaboration on patients' referrals to specific services described above, and progress reports on enrolled patients.
Conditions
- Osteoarthritis, Knee
- Osteoarthritis, Hip
- Overweight
- Obesity
- Physical Inactivity
- Weight Loss
Interventions
- BEHAVIORAL
-
OA CARE Intervention
Once assigned, participants will be contacted by the OA CARE Navigator to coordinate initiating a YMCA Medical Membership. Then, YMCA personnel will contact the participant to schedule the first Weight Loss Program (Program) group session. The Program will be delivered in groups with other OA CARE participants. Participants will also have access to all exercise facilities and programs at the YMCA during the study, and will be assigned a YMCA health coach. After initiation of the YMCA Medical Membership, the OA CARE Navigator will discuss participant's interests in referrals to other services related to osteoarthritis (OA) management. The Navigator will provide the participant's primary care provider (PCP) with a summary of this discussion and help the participant connect to any programs or resources that do not require provider referrals.
- BEHAVIORAL
-
Usual Care control group
Participants assigned to the usual care group will receive no additional treatment from the study for about 12 months. However, this group will be offered a 12-month Medical Membership to a local YMCA after completing the final assessment.
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
collaborator NIH -
University of North Carolina, Chapel Hill
lead OTHER
Principal Investigators
-
Kelli D Allen, PhD · University of North Carolina, Chapel Hill
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-07
- Primary Completion
- 2024-02-08
- Completion
- 2024-02-08
Countries
- United States
Study Locations
More Related Trials
-
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
NCT02447276 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Analgesic Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee
NCT00542555 ·Status: COMPLETED ·Phase: PHASE3
-
Intra-articular Adipose Tissue Injections for Osteoarthritis
NCT03242707 ·Status: UNKNOWN ·Phase: NA
-
Epidemiology of Osteoarthritis (OA) Pain
NCT01557231 ·Status: COMPLETED
-
Validation Study to Investigate the Effect of a New Treatment in Patients With Osteoarthritic Pain
NCT03174145 ·Status: COMPLETED ·Phase: NA
-
Osteoarthritis Initiative (OAI): A Knee Health Study
NCT00080171 ·Status: COMPLETED
-
Effect Of Celecoxib On Hip Osteoarthritis (OA) Progression
NCT00163241 ·Status: TERMINATED ·Phase: PHASE3
-
Structured Non-operative Treatment of Knee Osteoarthritis
NCT01535001 ·Status: COMPLETED ·Phase: NA
-
NSAID Treatment of Patients With Osteoarthritis
NCT02967744 ·Status: COMPLETED ·Phase: NA
-
Knee Osteoarthritis, Aging and Metabolic Syndrome
NCT05955573 ·Status: RECRUITING
-
Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis
NCT05430230 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Efficacy of AposTherapy® in Knee OA
NCT03153956 ·Status: TERMINATED ·Phase: NA
-
Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Osteoarthritis
NCT04627038 ·Status: COMPLETED ·Phase: PHASE2
-
An Effectiveness and Safety Study of IDEA-033 in Comparison to Oral Naproxen and Placebo for the Treatment of Osteoarthritis of the Knee
NCT00211549 ·Status: COMPLETED ·Phase: PHASE2
-
52 Week, International, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Clinical Trial to Compare Retention on Treatment, Safety, Tolerability & Efficacy of Lumiracoxib 100 mg od, Lumiracoxib 100 mg Bid & Celecoxib 200 mg od in Pts With Primary OA of Hip, Knee, Hand or Spine
NCT00145301 ·Status: COMPLETED ·Phase: PHASE3
-
A Study With GLPG1972 in Osteoarthritis Subjects
NCT03311009 ·Status: COMPLETED ·Phase: PHASE1
-
Use of Cooled Radiofrequency for the Treatment of Hip Pain Associated With OA of the Hip Compared to Intra-articular Steroid Injections
NCT03647332 ·Status: UNKNOWN ·Phase: NA
-
Toward Better Outcomes in Osteoarthritis
NCT00000425 ·Status: COMPLETED ·Phase: PHASE3
-
Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis
NCT05080660 ·Status: COMPLETED ·Phase: PHASE2
-
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
NCT01722864 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility Study of Anti-inflammatory Cytokines in Whole Blood in Osteoarthritis Patients
NCT01050894 ·Status: COMPLETED
-
IDEA-033 Three Months Dose Finding in OA Followed by IDEA-033 Three Months Extension in OA
NCT00316784 ·Status: COMPLETED ·Phase: PHASE3
-
Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip
NCT00174317 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacist-physiotherapist Collaborative Management for Early Knee Osteoarthritis
NCT06681142 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
NCT00541489 ·Status: COMPLETED ·Phase: PHASE3